A PROMIS Measure of Neuropathic Pain Quality

Value in Health

Volumn 19, Issue 5, 2016, Pages 623-630

  Askew, Robert L ^a   Cook, Karon F ^b   Keefe, Francis J ^c   Nowinski, Cindy J ^b   Cella, David ^b   Revicki, Dennis A ^d   Morgan DeWitt, Esi M ^e   Michaud, Kaleb ^f,g   Trence, Dace L ^h   Amtmann, Dagmar ^h  

^a STETSON UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

^d EVIDERA   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^g NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

measurement; neuropathy; pain; patient reported outcomes; PROMIS

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC PAIN; CONSTRUCT VALIDITY; CRITERION RELATED VALIDITY; DIABETIC NEUROPATHY; DISCRIMINANT VALIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROPATHIC PAIN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM NEUROPATHIC PAIN QUALITY SCALE; PATIENT-REPORTED OUTCOME; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RELIABILITY; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; AGED; DEVICES; NEURALGIA; PAIN MEASUREMENT; QUALITY OF LIFE; SELF REPORT; STANDARDS; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; QUALITY OF LIFE; SELF REPORT; TREATMENT OUTCOME;

EID: 84962467338     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2016.02.009     Document Type: Article

References (52)

1. [1] International Association for the Study of Pain Task Force on Taxonomy (IASP). Taxonomy. 2012, IASP Press, Seattle, WA.
2. [2] Sadosky, A., McDermott, A.M., Brandenburg, N.A., et al. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 8 (2008), 45–56.
3. [3] van Hecke, O., Austin, S.K., Khan, R.A., et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155 (2014), 654–662.
4. [4] Haanpää, M., Treede, R.-D., Diagnosis and classification of neuropathic pain. Pain Clin Update 18 (2010), 1–6.
5. [5] Freynhagen, R., Baron, R., Gockel, U., et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22 (2006), 1911–1920.
6. [6] Portenoy, R., Development and testing of a neuropathic pain screening questionnaire: ID pain. Curr Med Res Opin 22 (2006), 1555–1565.
7. [7] Jensen, M.P., Dworkin, R.H., Gammaitoni, A.R., et al. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6 (2005), 98–106.
8. [8] Jensen, M.P., Gammaitoni, A.R., Bolognese, J.A., et al. The pain quality response profile of pregabalin in the treatment of neuropathic pain. Clin J Pain 28 (2012), 683–686.
9. [9] Institute of Medicine (IOM). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. 2011, The National Academies Press, Washington, DC.
10. [10] Cella, D., Yount, S., Rothrock, N., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) progress of an NIH roadmap cooperative group during its first two years. Med Care, 45, 2007 S3–11.
11. [11] Amtmann, D., Cook, K.F., Jensen, M.P., et al. Development of a PROMIS item bank to measure pain interference. Pain 150 (2010), 173–182.
12. [12] Chen W-H, Revicki DA, Amtmann D, et al. Development and analysis of PROMIS Pain Intensity Scale. Presented at: The 18th Annual Conference of the International Society for Quality of Life Research, Denver, CO, 2012.
13. [13] Revicki, D.A., Chen, W.H., Harnam, N., et al. Development and psychometric analysis of the PROMIS pain behavior item bank. Pain 146 (2009), 158–169.
14. [14] Jones, R.C. III, Backonja, M.M., Review of neuropathic pain screening and assessment tools. Curr Pain Headache Rep, 17, 2013, 363.
15. [15] Mulvey, M.R., Bennett, M.I., Liwowsky, I., et al. The role of screening tools in diagnosing neuropathic pain. Pain Manag 4 (2014), 233–243.
16. [16] Revicki, D.A., Cook, K.F., Amtmann, D., et al. Exploratory and confirmatory factor analysis of the PROMIS pain quality item bank. Qual Life Res 23 (2014), 245–255.
17. [17] DeWalt, D.A., Rothrock, N., Yount, S., et al. Evaluation of item candidates: the PROMIS qualitative item review. Med Care 45 (2007), S12–S21.
18. [18] Cella, D., Riley, W., Stone, A., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63 (2010), 1179–1194.
19. [19] Reeve, B.B., Hays, R.D., Bjorner, J.B., et al. Psychometric evaluation and calibration of health-related quality of life item banks—plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 45 (2007), S22–S31.
20. [20] Bjorner, J.B., Rose, M., Gandek, B., et al. Method of administration of PROMIS scales did not significantly impact score level, reliability, or validity. J Clin Epidemiol 67 (2014), 108–113.
21. [21] Floyd, F.J., Widaman, K.F., Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess 7 (1995), 286–289.
22. [22] de Vet, H.C., Ader, H.J., Terwee, C.B., et al. Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36. Qual Life Res 14 (2005), 1203–1218 dicussion 19–21, 23–4.
23. [23] Knafl, G.J., Grey, M., Factor analysis model evaluation through likelihood cross-validation. Stat Methods Med Res 16 (2007), 77–102.
24. [24] Wood, N.D., Akloubou Gnonhosou, D.C., Bowling, J., Combining parallel and exploratory factor analysis in identifying relationship scales in secondary data. Marriage Fam Rev 51 (2015), 385–395.
25. [25] Dinno, A., Exploring the sensitivity of Horn's parallel analysis to the distributional form of random data. Multivariate Behav Res 44 (2009), 362–388.
26. [26] Fritz, C.O., Morris, P.E., Richler, J.J., Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 141 (2012), 2–18.
27. [27] Hu, L.T., Bentler, P.M., Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 6 (1999), 1–55.
28. [28] Kline, R.B., Principles and Practice of Structural Equation Modeling (3rd ed.). 2011, Guilford Press, New York, NY.
29. [29] Samejima, F., Estimation of Latent Ability Using a Response Pattern of Graded Scores. 1969, William Byrd Press, Richmond, VA.
30. [30] Embretson, S.E., Reise, S.P., Item Response Theory for Psychologists. 2000, Erlbaum, Mahwah, NJ.
31. [31] Reeve, B., Fayers, P., Applying item response theory modeling for evaluating questionnaire item and scale properties. Fayers, P., Hays, R., (eds.) Assessing Quality of Life in Clinical Trials: Methods of Practice (2nd ed.), 2005, Oxford University Press, New York, NY.
32. [32] Chen, W.H., Thissen, D., Local dependence indexes for item pairs: using item response theory. J Educ Behav Stat 22 (1997), 265–289.
33. [33] Orlando, M., Thissen, D., Further investigation of the performance of S-X-2: an item fit index for use with dichotomous item response theory models. Appl Psychol Meas 27 (2003), 289–298.
34. [34] Lalkhen, A.G., McCluskey, A., Clinical tests: sensitivity and specificity. Contin Educ Anaesth Crit Care Pain 8 (2008), 221–223.
35. [35] Dworkin, R.H., Turk, D.C., Revicki, D.A., et al. Development and initial validation of an expanded and revised version of the Short-Form McGill Pain Questionnaire (SF-MPQ-2). Pain 144 (2009), 35–42.
36. [36] Lovejoy, T.I., Turk, D.C., Morasco, B.J., Evaluation of the psychometric properties of the revised Short-Form McGill Pain Questionnaire. J Pain 13 (2012), 1250–1257.
37. [37] Bouhassira, D., Attal, N., Fermanian, J., et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108 (2004), 248–257.
38. [38] Sommer, C., Richter, H., Rogausch, J.P., et al. A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol, 11, 2011, 104.
39. [39] Bennett, M.I., Smith, B.H., Torrance, N., et al. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 6 (2005), 149–158.
40. [40] Galvez, R., Pardo, A., Ceron, J.M., et al. Linguistic adaptation into Spanish and psychometric validation of the ID-Pain© questionnaire for the screening of neuropathic pain. Med Clin (Barc) 131 (2008), 572–578.
41. [41] Backonja, M.M., Krause, S.J., Neuropathic pain questionnaire—short form. Clin J Pain 19 (2003), 315–316.
42. [42] Chan, A., Wong, S., Chen, P.P., et al. Validation study of the Chinese Identification Pain Questionnaire for neuropathic pain. Hong Kong Med J 17 (2011), 297–300.
43. [43] De Andres, J., Perez-Cajaraville, J., Lopez-Alarcon, M.D., et al. Cultural adaptation and validation of the painDETECT scale into Spanish. Clin J Pain 28 (2012), 243–253.
44. [44] Hallstrom, H., Norrbrink, C., Screening tools for neuropathic pain: can they be of use in individuals with spinal cord injury?. Pain 152 (2011), 772–779.
45. [45] Kitisomprayoonkul, W., Validation study of the Thai ID Pain Scale. J Med Assoc Thai 94 (2011), 610–615.
46. [46] Krause, S.J., Backonja, M.M., Development of a neuropathic pain questionnaire. Clin J Pain 19 (2003), 306–314.
47. [47] Padua, L., Briani, C., Truini, A., et al. Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. Neurol Sci 34 (2013), 373–377.
48. [48] Weingarten, T.N., Watson, J.C., Hooten, W.M., et al. Validation of the S-LANSS in the community setting. Pain 132 (2007), 189–194.
49. [49] Attal, N., Fermanian, C., Fermanian, J., et al. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?. Pain 138 (2008), 343–353.
50. [50] Clauw, D.J., Fibromyalgia: an overview. Am J Med, 122, 2009 S3–13.
51. [51] Rowbotham, M.C., Is fibromyalgia a neuropathic pain syndrome?. J Rheumatol Suppl 75 (2005), 38–40.
52. [52] Turk, D.C., Dworkin, R.H., Allen, R.R., et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 106 (2003), 337–345.